Jim Cramer Says This Former Covid Market Favorite May Finally Be Invested Again
modern Expanding the portfolio beyond infectious diseases is giving investors a new reason to own stocks after years of uncertainty…
Biotechnology and pharmaceuticals
Walmart and CVS step in to help seniors
A version of this article first appeared in CNBC's Healthy Returns newsletter, bringing the latest healthcare news directly to your…
Abivax shares soar after new data on drugs for intestinal diseases
Shares of a French biotechnology company Abivax surged on Tuesday after it released new data on its lead drug for…
Medicare Will Soon Cover Obesity Medications, But Many Seniors May Not Know It
Wegovy weight loss treatment injectable pens, manufactured by Novo Nordisk A/S, on display during a press conference in Mumbai, India,…
Centene to offer terminations to some employees
Sheldon Cooper | Light rocket | fake images rye said it offered buyouts to some employees on Monday, as the…
Chan Zuckerberg Biohub to open new round of funding for rare diseases
Biohub, a nonprofit research organization funded by the Chan Zuckerberg Initiative, announced Thursday that it will open another round of…
Estrogen patches in short supply as women seek menopause support
Woman applying estrogen patch during hormone therapy. Half point images | Moment | fake images Estrogen patches are in short…
This life sciences stock has a secret weapon and AI will only make it more valuable
IQVIA, with its vast trove of health information, is at the center of drug development, providing data, tools and services…
What's next for the weight-loss drug maker?
Shares in Danish biotech Zealand Pharma plunged recently after detailed data on its weight-loss drug survodutide showed much higher patient…
Huntington's disease drug maker UniQure to seek FDA approval for gene therapy
Thomas Fuller | SOPA Images | Light rocket | fake images UniQure plans to seek FDA approval for its experimental…